DrugCite
Search

HUMULIN R

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Humulin R Adverse Events Reported to the FDA Over Time

How are Humulin R adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Humulin R, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Humulin R is flagged as the suspect drug causing the adverse event.

Most Common Humulin R Adverse Events Reported to the FDA

What are the most common Humulin R adverse events reported to the FDA?

Blood Glucose Increased
741 (6.79%)
Blood Glucose Decreased
337 (3.09%)
Drug Exposure During Pregnancy
333 (3.05%)
Drug Ineffective
250 (2.29%)
Hypoglycaemia
182 (1.67%)
Loss Of Consciousness
128 (1.17%)
Hospitalisation
123 (1.13%)
Myocardial Infarction
123 (1.13%)
Blood Glucose Fluctuation
119 (1.09%)
Diabetes Mellitus Inadequate Contro...
115 (1.05%)
Cerebrovascular Accident
114 (1.04%)
Show More Show More
Fall
98 (.9%)
Visual Acuity Reduced
94 (.86%)
Malaise
87 (.8%)
Feeling Abnormal
85 (.78%)
Blindness
81 (.74%)
Incorrect Dose Administered
80 (.73%)
Cardiac Disorder
75 (.69%)
Dyspnoea
74 (.68%)
Hyperglycaemia
69 (.63%)
Premature Baby
66 (.6%)
Asthenia
65 (.6%)
Medication Error
62 (.57%)
Cataract
60 (.55%)
Renal Failure
58 (.53%)
Headache
57 (.52%)
Convulsion
56 (.51%)
Dizziness
56 (.51%)
Oedema Peripheral
54 (.49%)
Weight Increased
54 (.49%)
Vomiting
53 (.49%)
Weight Decreased
53 (.49%)
Eye Haemorrhage
52 (.48%)
Pneumonia
51 (.47%)
Wrong Drug Administered
51 (.47%)
Hypertension
50 (.46%)
Death
49 (.45%)
Fatigue
48 (.44%)
Abortion Spontaneous
47 (.43%)
Hyperhidrosis
46 (.42%)
Memory Impairment
45 (.41%)
Renal Disorder
44 (.4%)
Drug Hypersensitivity
43 (.39%)
Pain In Extremity
43 (.39%)
Visual Impairment
43 (.39%)
Glycosylated Haemoglobin Increased
42 (.38%)
Tremor
42 (.38%)
Diabetic Ketoacidosis
41 (.38%)
Infection
41 (.38%)
Arthralgia
40 (.37%)
Cardiac Failure Congestive
39 (.36%)
Chronic Obstructive Pulmonary Disea...
39 (.36%)
Drug Dispensing Error
38 (.35%)
Nausea
38 (.35%)
Pain
38 (.35%)
Amnesia
37 (.34%)
Diarrhoea
37 (.34%)
Chest Pain
36 (.33%)
Hypersensitivity
36 (.33%)
Pyrexia
36 (.33%)
Diabetic Retinopathy
35 (.32%)
Blindness Unilateral
33 (.3%)
Confusional State
32 (.29%)
Drug Dose Omission
31 (.28%)
Hypoglycaemic Coma
31 (.28%)
Vision Blurred
31 (.28%)
Arthritis
29 (.27%)
Dialysis
28 (.26%)
Hypoaesthesia
27 (.25%)
Pruritus
27 (.25%)
Road Traffic Accident
27 (.25%)
Dehydration
26 (.24%)
Expired Drug Administered
26 (.24%)
Rash
26 (.24%)
Coma
25 (.23%)
Gait Disturbance
25 (.23%)
Haemorrhage
25 (.23%)
Hypoglycaemic Unconsciousness
25 (.23%)
Insulin Resistance
25 (.23%)
Limb Injury
25 (.23%)
Anxiety
24 (.22%)
Bedridden
24 (.22%)
Blood Pressure Decreased
24 (.22%)
Depressed Level Of Consciousness
24 (.22%)
Emphysema
24 (.22%)
Hypoglycaemia Unawareness
24 (.22%)
Neuropathy Peripheral
24 (.22%)
Stent Placement
24 (.22%)
Toe Amputation
24 (.22%)
Abasia
23 (.21%)
Blood Glucose Abnormal
23 (.21%)
Cellulitis
23 (.21%)
Depression
23 (.21%)
Eye Disorder
23 (.21%)
Injection Site Pain
23 (.21%)
Mobility Decreased
23 (.21%)
Staphylococcal Infection
23 (.21%)
Blood Pressure Increased
22 (.2%)
Insomnia
22 (.2%)
Macular Degeneration
22 (.2%)
Urticaria
22 (.2%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Humulin R, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humulin R is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Humulin R

What are the most common Humulin R adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Humulin R, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Humulin R is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Humulin R According to Those Reporting Adverse Events

Why are people taking Humulin R, according to those reporting adverse events to the FDA?

Diabetes Mellitus
2105
Type 2 Diabetes Mellitus
253
Type 1 Diabetes Mellitus
160
Gestational Diabetes
124
Diabetes Mellitus Insulin-dependent
114
Product Used For Unknown Indication
110
Show More Show More
Drug Use For Unknown Indication
95
Diabetes Mellitus Non-insulin-depen...
76
Hyperglycaemia
47
Blood Glucose Increased
32
Blood Glucose
9
Prophylaxis
8
Blood Glucose Fluctuation
7
Insulin-requiring Type Ii Diabetes ...
5
Hypoglycaemia
5
Blood Insulin
4
Diabetic Ketoacidosis
3
Blood Glucose Abnormal
3
Post Herpetic Neuralgia
3
Metabolic Disorder
2
Pancreatic Disorder
2
Parenteral Nutrition
2
Renal Failure Chronic
2
Angiopathy
2
Off Label Use
2
Hepatic Function Abnormal
2
Allergenic Desensitisation Procedur...
1
Jaundice
1
Depression
1
Abortion Threatened
1
Glucose Tolerance Impaired
1
Chronic Myeloid Leukaemia
1
Ill-defined Disorder
1
Diabetic Coma
1
Suicide Attempt
1
Insulin Resistance
1
Pancreatogenous Diabetes
1
Surgery
1
Hyperkalaemia
1
Renal Failure Acute
1

Drug Labels

LabelLabelerEffective
Humulin R Physicians Total Care, Inc.08-NOV-10
Humulin R Eli Lilly and Company12-FEB-13
Humulin R Eli Lilly and Company 09-MAR-13

Humulin R Case Reports

What Humulin R safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Humulin R. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Humulin R.